Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria, Muscle | 7 | 2026 | 25 | 1.680 |
Why?
|
| Muscle, Skeletal | 11 | 2026 | 316 | 1.310 |
Why?
|
| Mitochondria | 8 | 2026 | 523 | 0.790 |
Why?
|
| Energy Metabolism | 7 | 2024 | 187 | 0.740 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 539 | 0.570 |
Why?
|
| Stress, Psychological | 1 | 2025 | 661 | 0.570 |
Why?
|
| Muscular Dystrophy, Duchenne | 3 | 2024 | 12 | 0.520 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 830 | 0.510 |
Why?
|
| HIV Infections | 2 | 2025 | 2586 | 0.510 |
Why?
|
| Aging | 5 | 2024 | 783 | 0.500 |
Why?
|
| Informed Consent | 1 | 2016 | 35 | 0.490 |
Why?
|
| Electronic Health Records | 1 | 2016 | 108 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2024 | 92 | 0.440 |
Why?
|
| Male | 18 | 2026 | 23409 | 0.320 |
Why?
|
| Mice, Inbred mdx | 3 | 2024 | 8 | 0.300 |
Why?
|
| Oxidative Phosphorylation | 6 | 2026 | 60 | 0.290 |
Why?
|
| Aged | 10 | 2026 | 8214 | 0.280 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2020 | 131 | 0.250 |
Why?
|
| Sodium Nitrite | 1 | 2026 | 5 | 0.240 |
Why?
|
| Nitrites | 1 | 2026 | 55 | 0.240 |
Why?
|
| Mitochondrial Diseases | 1 | 2026 | 20 | 0.240 |
Why?
|
| Aged, 80 and over | 7 | 2026 | 2853 | 0.240 |
Why?
|
| Humans | 18 | 2026 | 43102 | 0.230 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 457 | 0.230 |
Why?
|
| Muscle Fatigue | 1 | 2024 | 9 | 0.220 |
Why?
|
| Creatine | 1 | 2024 | 10 | 0.220 |
Why?
|
| Osteoarthritis, Knee | 1 | 2024 | 15 | 0.220 |
Why?
|
| Female | 13 | 2026 | 24698 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2026 | 213 | 0.210 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 16 | 0.210 |
Why?
|
| Body Mass Index | 2 | 2024 | 925 | 0.180 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 719 | 0.180 |
Why?
|
| Hydrogen Peroxide | 2 | 2019 | 190 | 0.170 |
Why?
|
| Mice | 9 | 2024 | 6644 | 0.160 |
Why?
|
| Adenosine Triphosphate | 3 | 2024 | 206 | 0.150 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 29 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2020 | 171 | 0.150 |
Why?
|
| Achromobacter denitrificans | 1 | 2017 | 1 | 0.140 |
Why?
|
| Siderophores | 1 | 2018 | 15 | 0.140 |
Why?
|
| Oxygen Consumption | 3 | 2025 | 110 | 0.140 |
Why?
|
| Leukotriene B4 | 1 | 2017 | 8 | 0.140 |
Why?
|
| Macrophages, Alveolar | 1 | 2017 | 34 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 28 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 112 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 58 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 989 | 0.130 |
Why?
|
| Access to Information | 1 | 2016 | 15 | 0.130 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2016 | 9 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 561 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 26 | 0.120 |
Why?
|
| Confidentiality | 1 | 2016 | 29 | 0.120 |
Why?
|
| New York | 1 | 2016 | 93 | 0.120 |
Why?
|
| Pancreas | 1 | 2016 | 45 | 0.120 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2016 | 6 | 0.120 |
Why?
|
| Animals | 10 | 2026 | 16992 | 0.120 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 13 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2016 | 74 | 0.120 |
Why?
|
| Adult | 3 | 2025 | 13872 | 0.120 |
Why?
|
| Young Adult | 2 | 2025 | 5080 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 183 | 0.120 |
Why?
|
| New York City | 1 | 2016 | 288 | 0.120 |
Why?
|
| Middle Aged | 2 | 2024 | 12222 | 0.120 |
Why?
|
| Nursing Informatics | 1 | 2015 | 1 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2016 | 452 | 0.110 |
Why?
|
| Lung | 1 | 2017 | 492 | 0.110 |
Why?
|
| Focus Groups | 1 | 2016 | 423 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 210 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 231 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 178 | 0.100 |
Why?
|
| United States | 1 | 2025 | 5205 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2018 | 1035 | 0.100 |
Why?
|
| Adolescent | 1 | 2025 | 6081 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2016 | 574 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 1596 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 758 | 0.090 |
Why?
|
| Sex Factors | 2 | 2024 | 1028 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 495 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 968 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2026 | 81 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2026 | 317 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2026 | 260 | 0.060 |
Why?
|
| Creatine Kinase, Mitochondrial Form | 1 | 2024 | 1 | 0.060 |
Why?
|
| Phosphocreatine | 1 | 2024 | 12 | 0.060 |
Why?
|
| Mobility Limitation | 1 | 2024 | 21 | 0.050 |
Why?
|
| Exercise Test | 1 | 2024 | 74 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2026 | 191 | 0.050 |
Why?
|
| Quadriceps Muscle | 1 | 2024 | 8 | 0.050 |
Why?
|
| Body Fat Distribution | 1 | 2024 | 26 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2024 | 37 | 0.050 |
Why?
|
| Inulin | 1 | 2024 | 3 | 0.050 |
Why?
|
| Prebiotics | 1 | 2024 | 7 | 0.050 |
Why?
|
| Butyrates | 1 | 2024 | 34 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2024 | 46 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2023 | 18 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2024 | 38 | 0.050 |
Why?
|
| Muscles | 1 | 2023 | 82 | 0.050 |
Why?
|
| Leg | 1 | 2023 | 19 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 78 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 74 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2024 | 182 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1869 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 587 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2020 | 17 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 192 | 0.040 |
Why?
|
| Gentisates | 1 | 2018 | 2 | 0.030 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2019 | 123 | 0.030 |
Why?
|
| alpha-Defensins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2017 | 64 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 160 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 2157 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 86 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 256 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 283 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 4 | 0.030 |
Why?
|
| Kallikrein-Kinin System | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2016 | 10 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 258 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 251 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3156 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 105 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 491 | 0.030 |
Why?
|
| Taiwan | 1 | 2015 | 23 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 49 | 0.030 |
Why?
|
| Students, Nursing | 1 | 2015 | 38 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 299 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1621 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 667 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1003 | 0.020 |
Why?
|
| Exercise | 1 | 2018 | 692 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3735 | 0.020 |
Why?
|